Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul-Aug;47(4):354-9.
doi: 10.4103/0253-7613.161249.

Imiquimod - Its role in the treatment of cutaneous malignancies

Aditya Kumar Bubna  1
Affiliations
Review

Imiquimod - Its role in the treatment of cutaneous malignancies

Aditya Kumar Bubna. Indian J Pharmacol. 2015 Jul-Aug.

Abstract

Imiquimod is a synthetic imidazoquinolone amine, which has potent immune response modifier activity, when topically used. This characteristic property of imiquimod has led to its use in a number of applications in dermatology, particularly in cutaneous malignancies, where it has been found to be effective and safe. Currently, additional mechanisms for its activity in actinic keratosis, basal cell carcinoma, and invasive squamous cell carcinoma have been elucidated. Its usage for cutaneous metastasis in breast cancer has been a further addition to its therapeutic armamentarium recently.

Keywords: Cutaneous malignancies; imidazoquinolone; imiquimod.

PubMed Disclaimer

References

    1. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43:S6–11. - PubMed
    1. Navi D, Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J. 2004;10:4. - PubMed
    1. Leverkus M. Imiquimod: Unexpected killer. J Invest Dermatol. 2004;122:XV–XVI. - PubMed
    1. Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002–7. - PubMed
    1. Jobanputra KS, Rajpal AV, Nagpur NG. Imiquimod. Indian J Dermatol Venereol Leprol. 2006;72:466–9. - PubMed

MeSH terms